Vertex Pharmaceuticals Inc. 8-K Report: Key Corporate Events on November 3, 2025
Based on the provided section of the financial report, here are the key insights and information extracted:
- Entity Information:
- Company Name: Vertex Pharmaceuticals Inc.
- CIK Number: 0000875320
- Location: 50 Northern Avenue, Boston, MA 02210
- Contact Number: 617-341-6100
- Filing Details:
- Filing Type: 8-K (a report of unscheduled material events or corporate changes)
- Filing Date: November 3, 2025
- SEC Central Index Key (CIK): 0000875320
- Securities Exchange: NASDAQ
- Stock Ticker Symbol: VRTX
- Par Value of Common Stock: $0.01
- Period of Report:
- Start Date: November 3, 2025
- End Date: November 3, 2025
- Regulatory Compliance:
- This filing follows the SEC regulations and includes relevant identification details such as the schema reference for XBRL (eXtensible Business Reporting Language) compliance.
Summary:
The report indicates that Vertex Pharmaceuticals filed an 8-K on November 3, 2025, detailing potentially significant corporate events. The filing includes essential company identification information and is compliant with SEC requirements, suggesting active management of public disclosure obligations.
